Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHIEF OPERATING OFFICER Moat Ross converted options into 8,285 units of Class A Ordinary Share and covered exercise/tax liability with 4,007 units of Class A Ordinary Share, increasing direct ownership by 36% to 16,307 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.